Gene: STAC
Official Full Name: SH3 and cysteine rich domainprovided by HGNC
Gene Summary: Predicted to enable transmembrane transporter binding activity. Predicted to be involved in positive regulation of protein localization to plasma membrane; positive regulation of voltage-gated calcium channel activity; and skeletal muscle contraction. Predicted to act upstream of or within cellular response to heat; muscle contraction; and regulation of voltage-gated calcium channel activity. Predicted to be located in cytoplasmic side of plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35210 | STAC Knockout cell line (HeLa) | Human | STAC | 1:3~1:6 | Negative | Online Inquiry |
KO35211 | STAC Knockout cell line (HEK293) | Human | STAC | 1:3~1:6 | Negative | Online Inquiry |
KO35212 | STAC Knockout cell line (A549) | Human | STAC | 1:3~1:4 | Negative | Online Inquiry |
STAC Gene Knockout Cell Lines are engineered cell lines that have been specifically designed to facilitate the study of gene function and the phenotypic consequences of gene loss. Utilizing advanced CRISPR/Cas9 genome editing technology, these cell lines are developed to stably knock out specific genes of interest, allowing researchers to investigate the roles these genes play in various biological processes. Each cell line is meticulously validated to ensure that the target gene is effectively disrupted, resulting in clear and reproducible experimental outcomes.
The primary function of STAC Gene Knockout Cell Lines lies in their ability to provide researchers with a controlled environment to study gene expression, signaling pathways, and cellular responses without the interference of the target gene. By observing the phenotypic effects of gene knockout, scientists can gain valuable insights into gene functions and their implications in disease mechanisms. This makes these cell lines invaluable tools in fields such as cancer research, developmental biology, and pharmacogenomics.
In a clinical context, STAC Gene Knockout Cell Lines offer substantial benefits for drug discovery and the development of novel therapeutics. For instance, by simulating disease states through gene disruption, researchers can evaluate potential drug targets and assess the efficacy of new pharmacological agents. The ability to create a direct correlation between genetic alterations and cellular behavior provides a powerful method to identify biomarkers for disease and therapeutic intervention.
Compared to traditional knockout methods, STAC Gene Knockout Cell Lines stand out with their ease of use, reproducibility, and rapid development timelines. Furthermore, their availability in various cell types expands their utility across different research disciplines, making them versatile tools underpinned by solid scientific principles.
For researchers and clinicians aiming to unravel the complexities of gene function and apply their findings to innovative therapeutic approaches, STAC Gene Knockout Cell Lines present an adaptable, reliable, and scientifically robust option. Supported by our company's extensive experience in genomic innovations and commitment to delivering high-quality biological products, we equip researchers with the tools necessary to advance their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.